Clinical and prognostic association of transcription factor SOX4 in gastric cancer.

Gastric cancer (GC) is one of the most common malignant cancers worldwide. However, little is known about the molecular process by which this disease develops and progresses. This study investigated correlations between the expression of nuclear transcription factor SOX4 and various clinicopathologi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chia-Lang Fang, You-Cheng Hseu, Yi-Feng Lin, Shih-Ting Hung, Chein Tai, Yih-Huei Uen, Kai-Yuan Lin
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/bbfdf654ea464529b74bd004871d64a2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bbfdf654ea464529b74bd004871d64a2
record_format dspace
spelling oai:doaj.org-article:bbfdf654ea464529b74bd004871d64a22021-11-18T08:04:02ZClinical and prognostic association of transcription factor SOX4 in gastric cancer.1932-620310.1371/journal.pone.0052804https://doaj.org/article/bbfdf654ea464529b74bd004871d64a22012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23285187/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Gastric cancer (GC) is one of the most common malignant cancers worldwide. However, little is known about the molecular process by which this disease develops and progresses. This study investigated correlations between the expression of nuclear transcription factor SOX4 and various clinicopathologic parameters as well as patients' survival. Expression levels of nuclear SOX4 were analyzed by immunohistochemistry; the data comprised gastric tissues from 168 patients with GC. Paired t tests were used to analyze the differences in nuclear SOX4 expression between tumor and non-tumor tissues from each patient. Two-tailed Χ(2) tests were performed to determine whether the differences in nuclear SOX4 expression and clinicopathologic parameters were significant. Time-to-event endpoints for clinicopathologic parameters were plotted using the Kaplan-Meier method, and statistical significance was determined using univariate log-rank tests. Cox proportional hazard model was used for multivariate analysis to determine the independence of prognostic effects of nuclear SOX4 expression. Overexpression of nuclear SOX4 was significantly correlated with depth of invasion (P<0.0001), nodal status (P=0.0055), distant metastasis (P=0.0195), stage (P=0.0003), and vascular invasion (P=0.0383). Patients who displayed high expression levels of nuclear SOX4 achieved a significantly poorer disease-free survival rate, compared with patients with low SOX4 expression levels (P=0.003). Univariate Cox regression analysis showed that overexpression of nuclear SOX4 was a clear prognostic marker for GC (P=0.004). Overexpression of nuclear SOX4 can be used as a marker to predict the outcome of patients with GC.Chia-Lang FangYou-Cheng HseuYi-Feng LinShih-Ting HungChein TaiYih-Huei UenKai-Yuan LinPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 12, p e52804 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Chia-Lang Fang
You-Cheng Hseu
Yi-Feng Lin
Shih-Ting Hung
Chein Tai
Yih-Huei Uen
Kai-Yuan Lin
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
description Gastric cancer (GC) is one of the most common malignant cancers worldwide. However, little is known about the molecular process by which this disease develops and progresses. This study investigated correlations between the expression of nuclear transcription factor SOX4 and various clinicopathologic parameters as well as patients' survival. Expression levels of nuclear SOX4 were analyzed by immunohistochemistry; the data comprised gastric tissues from 168 patients with GC. Paired t tests were used to analyze the differences in nuclear SOX4 expression between tumor and non-tumor tissues from each patient. Two-tailed Χ(2) tests were performed to determine whether the differences in nuclear SOX4 expression and clinicopathologic parameters were significant. Time-to-event endpoints for clinicopathologic parameters were plotted using the Kaplan-Meier method, and statistical significance was determined using univariate log-rank tests. Cox proportional hazard model was used for multivariate analysis to determine the independence of prognostic effects of nuclear SOX4 expression. Overexpression of nuclear SOX4 was significantly correlated with depth of invasion (P<0.0001), nodal status (P=0.0055), distant metastasis (P=0.0195), stage (P=0.0003), and vascular invasion (P=0.0383). Patients who displayed high expression levels of nuclear SOX4 achieved a significantly poorer disease-free survival rate, compared with patients with low SOX4 expression levels (P=0.003). Univariate Cox regression analysis showed that overexpression of nuclear SOX4 was a clear prognostic marker for GC (P=0.004). Overexpression of nuclear SOX4 can be used as a marker to predict the outcome of patients with GC.
format article
author Chia-Lang Fang
You-Cheng Hseu
Yi-Feng Lin
Shih-Ting Hung
Chein Tai
Yih-Huei Uen
Kai-Yuan Lin
author_facet Chia-Lang Fang
You-Cheng Hseu
Yi-Feng Lin
Shih-Ting Hung
Chein Tai
Yih-Huei Uen
Kai-Yuan Lin
author_sort Chia-Lang Fang
title Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
title_short Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
title_full Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
title_fullStr Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
title_full_unstemmed Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
title_sort clinical and prognostic association of transcription factor sox4 in gastric cancer.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/bbfdf654ea464529b74bd004871d64a2
work_keys_str_mv AT chialangfang clinicalandprognosticassociationoftranscriptionfactorsox4ingastriccancer
AT youchenghseu clinicalandprognosticassociationoftranscriptionfactorsox4ingastriccancer
AT yifenglin clinicalandprognosticassociationoftranscriptionfactorsox4ingastriccancer
AT shihtinghung clinicalandprognosticassociationoftranscriptionfactorsox4ingastriccancer
AT cheintai clinicalandprognosticassociationoftranscriptionfactorsox4ingastriccancer
AT yihhueiuen clinicalandprognosticassociationoftranscriptionfactorsox4ingastriccancer
AT kaiyuanlin clinicalandprognosticassociationoftranscriptionfactorsox4ingastriccancer
_version_ 1718422310230163456